Numinus Wellness Inc. (OTCMKTS:NUMIF – Get Rating) was the recipient of a large decline in short interest during the month of December. As of December 30th, there was short interest totalling 236,600 shares, a decline of 28.8% from the December 15th total of 332,200 shares. Based on an average daily trading volume, of 421,200 shares, the days-to-cover ratio is currently 0.6 days.
Wall Street Analyst Weigh In
Separately, Maxim Group initiated coverage on Numinus Wellness in a research note on Thursday, December 8th. They set a "positive" rating and a $0.50 price target on the stock.
Get
Numinus Wellness alerts:
Numinus Wellness Price Performance
Shares of NUMIF stock remained flat at C$0.21 on Friday. The stock had a trading volume of 62,783 shares, compared to its average volume of 124,483. Numinus Wellness has a fifty-two week low of C$0.11 and a fifty-two week high of C$0.65.
About Numinus Wellness
(Get Rating)
Numinus Wellness Inc provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health. The company operates through three segments: Research Operations, Canadian Clinic Network, and U.S Clinic Network. The Research Operations segment offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics.
Featured Articles
- Get a free copy of the StockNews.com research report on Numinus Wellness (NUMIF)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Numinus Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Numinus Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
纳米纳斯健康公司(OTCMKTS：NUMIF-GET Rating)是空头股数12月份股价大幅下跌的接收方。截至12月30日，空头股数共有236,600股，较12月15日的332,200股下降28.8%。以日均成交量421,200股计算，目前天数与回补比率为0.6天。
华尔街分析师也加入进来
另外，Maxim Group在12月8日星期四的一份研究报告中发起了对努米纳斯健康的报道。他们为该股设定了“正面”评级和0.50美元的目标价。
到达
努米诺斯健康警报：
纽米诺健康性价比
周五，NUMIF的股票持平于0.21加元。该股成交量为62,783股，而其平均成交量为124,483股。Nnuus Wellness的52周低点为0.11加元，52周高位为0.65加元。
关于努米诺斯的健康
(获取评级)
努米纳斯健康公司提供解决方案，以开发和提供迷幻辅助心理治疗，并改变心理健康。该公司通过三个部门运营：研究运营、加拿大临床网络和美国临床网络。研究运营部门提供实验室服务，如种植、分析测试、产品研究和开发，以及迷幻药领域的辅助服务。
专题文章
- 免费获取StockNews.com关于努米纳斯健康的研究报告(NUMIF)
- 市场回顾周-1/16-1/20
- Old Dominion是否表明Trucking正在踩刹车？
- 诺德斯特龙对零售业降价的担忧
- 埃克森美孚股票：在Buy Point附近
- 高股息率的必和必拓认为中国推动了23年的增长
接受《努米纳斯健康日报》的新闻和评级-在下面输入您的电子邮件地址，即可通过MarketBeat.com的免费每日电子邮件时事通讯，获得对努米纳斯健康和相关公司的最新新闻和分析师评级的每日简要摘要。
